WBO middleweight champ Billy Joe Saunders fails drug test ahead of title defen | Boxing
Billy Joe Saunders hasn’t had the greatest of months. It just got a lot worse.
ESPN.com is reporting the WBO middleweight champion has failed a drug test that was administered by Voluntary Anti-Doping Association for the banned substance Oxilofrine, a stimulant.
Saunders (26-0, 12 KOs) is scheduled to defend his title for the fourth time against Demetrius Andrade on DAZN from the TD Garden in Boston on Oct. 20.
Saunders’ promoter Frank Warren released a statement to Sporting News confirming the test results. He explained that Oxilofrine is allowed while a fighter is out-of-competiton and
“Following reports of an adverse analytical finding in a test carried out by the Voluntary Anti-Doping Association (“VADA”) on WBO World Middleweight Champion, Billy Joe Saunders, we can confirm that the product concerned is permitted to be used ‘Out of Competition’ by United Kingdom Anti-Doping (“UKAD”) in line with the regulations of the World Anti-Doping Agency (“WADA”),” Warren said.
“For the avoidance of doubt, the product in question was a common decongestant nasal spray. The British Boxing Board of Control (“BBBofC”) under whose jurisdiction Billy Joe Saunders is licensed are affiliated only to UKAD/WADA. Today the BBBofC have confirmed that Mr Saunders is not in breach of BBBofC or UKAD anti doping regulations and is therefore in good standing and is licensed to box and defend his World Title on October 20th.
“Mr. Saunders has been tested a number of times in 2018, all negative, his last out of competition test by UKAD was on 24th September 2018.”
The status of the fight is unknown.
On Tuesday, Saunders was fined £100,000 ($131,000 USD) by The British Boxing Board of Control after the 29-year-old was recorded in a video offering a woman drugs in exchange for performing a sex act. Saunders apologized for the incident.